Q2 2025 Earnings Call Transcript August 1, 2025 Ocugen, Inc. beats earnings expectations. Reported EPS is $-0.05, ...

There’s a lot to say about the economy and markets today. Earnings season is well underway, with 317 S&P 500 companies having ...

July marks a transformative month in oncology with the FDA's groundbreaking approvals and updates, enhancing treatment ...

(NASDAQ:MRNA) today reported financial results and provided business updates for the second quarter of 2025. "In the last three months, we advanced our pipeline with positive Phase 3 flu vaccine ...

The court should adopt a narrow view of the Mann Act, the legal team states in a new filing, calling its application in Sean ...

After a decade of development, a Kansas City-based pharmaceutical company is on the brink of submitting its ADHD medication ...

SHELTON, CT / ACCESS Newswire / July 30, 2025 / NanoViricides, Inc., a publicly traded company (NYSE Amer.:NNVC) (the “Company”), and a clinical stage, leading global pioneer in the development of ...

The FDA greenlit multiple new drugs this month and issued some notable label expansions, including for Eli Lilly’s Kisunla.

The key news from the release was that while the company outperformed revenue estimates—reporting $28.2 million (GAAP) compared to the expected $27.03 million—profitability came under pressure, with a ...

The Trace spoke to a Yale law professor about the strengths and weaknesses of the Justice Department’s proposal.

AbbVie submitted a supplemental new drug application for Venclexta plus Calquence treatment in previously untreated chronic ...

PainChek, EMVision and Clever Culture Systems are among ASX health companies reporting quarterly results today.